Two of MGI’s subsidiaries signed a licensing deal with Swiss Rockets to grant it an exclusive patent license for MGI’s ...

Complete Genomics, a leading innovator in genomic sequencing, today announced at the American Society of Human Genetics Annual Meeting that it has added Houston-based Gene by Gene, a leading genetics ...

Metagenomi announces successful integration of large genes in human cells using a novel, compact CAST system for potential therapeutic applications. Metagenomi, Inc., a precision genetic medicines ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Gene editing is precise enough to address a variety of needs. Researchers harness gene-editing to revolutionize how we grow ...

Founded in 2020 by Chilean biochemist Bernardo Pollak, Meristem is using precise gene editing techniques to develop local ...

Cibus, Inc., a leading agricultural biotechnology firm, announced that Co-Founder and Interim CEO Peter Beetham will present at the AGP Annual Virtual Healthcare Company Showcase on May 21, 2025. He ...

While some scientists argue that agricultural gene editing regulations are overly restrictive, a new paper from the University of Adelaide emphasises the importance of clear regulations to ensure new ...

Disease-resistant pigs, faster-growing fish and heat-tolerant cows are among a new class of animals that are being genetically engineered for the dining table. Similar meat products could soon be sold ...

EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within ...

The agreement gives Chiesi exclusive rights for the development and commercialisation of ABO-101 to treat PH1.